- Action
- Gentherm issued URGENT Medical Device Correction, Blanketrol II letters were mailed by USPS starting July 25th and Blanketrol III letters were mailed by USPS starting July 30th. Letters stated problem, health risk and action to take: INSTRUCTIONS TO CUSTOMERS:
1) Access updated manuals and ensure that obsolete manuals are removed from service. Updated manuals may be accessed via www.gentherm.com or physical copies may be requested from Gentherm Medical, LLC at (513)326-5320.
2) Ensure that all users are informed of the contents of this letter. If you have further distributed this product, please provide those accounts with a copy of this notice.
3) Please complete and return the enclosed response form as soon as possible to acknowledge receipt of this notification and to inform Gentherm Medical, LLC that you have performed and completed the requested actions. Return the form by e-mail to FA2019-004/010@gentherm.com, or mail to: Gentherm Medical, LLC, 12011 Mosteller Road, Cincinnati, OH 45241.
Questions, call Gentherm Medical Technical Support at 1-888-437-5608 or Stephanie Vocke @ (513)719-3262
- Initiated
- 2019-07-02
- Root cause
- Labeling False and Misleading
- Terminated
- 2020-06-22
- Distribution
- Worldwide distribution - US Nationwide and countries of
Afghanistan, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Belgium, Bhutan, Brazil, Brunei, Canada
Chile, China, Colombia, Costa Rica, Ecuador, Egypt, El Salvador, France, Germany, Guatemala, Hong Kong, India, Indonesia, Israel, Italy, Japan, Kazakhstan, Kenya, Kuwait,
Lebanon, Malaysia, Mexico, Morocco, Nepal, Netherlands,
New Zealand, Oman, Pakistan, Palestine, Panama,
Philippines, Qatar, Saudi Arabia, Singapore, South Africa,
South Korea, Spain, Taiwan, Thailand, Trinidad and Tobago,
Turkey, United Arab Emirates, Venezuela, Vietnam.
- Recall number
- Z-0419-2020
- Recall status
- Terminated
- CDRH record ID
- 175309
- FDA record created
- 2019-11-18
- Recall event number
- 83464